# data[].attributes.headline
Session Formats at the 2020 ASCO Annual Meeting

# data[].attributes.subject
Session Formats at the 2020 ASCO Annual Meeting

# data[].attributes.body
Dr. Jagjit Tandon is the founder of oncology and hematology practice, Bradford Oncology. Committed to professional practice, Dr. Jagjit Tandon is a member of the American Society of Clinical Oncology (ASCO) and regularly attends its annual meetings.

# data[].attributes.headline
ASH Commends Congress for Reaching Spending Deal

# data[].attributes.subject
ASH Commends Congress for Reaching Spending Deal

# data[].attributes.body
Drawing on several decades of experience, Dr. Jagjit Tandon is a medical professional who serves as the director and CEO of Bradford Oncology, a practice he established in 2007. Throughout his career, Dr. Jagjit Tandon has been involved with several organizations, including the American Society of Hematology (ASH), which looks to advance blood disease research.

# data[].attributes.attachment_link.readable_text
Drawing on several decades of experience, Dr. Jagjit Tandon is a medical professional who serves as the director and CEO of Bradford Oncology, a practice he established in 2007. Throughout his career, Dr. Jagjit Tandon has been involved with several organizations, including the American Society of Hematology (ASH), which looks to advance blood disease research.

The non-profit recently responded to a $1.3 trillion federal spending deal passed by Congress in December for the coming fiscal year. ASH President Stephanie Lee, MD, welcomed the deal, with gives $8 billion in funding to the Centers for Disease Control and Prevention (CDC), as well as $41.7 billion that will go to the National Institutes of Health (NIH).

Dr. Lee notes that both organizations play pivotal roles in advancing medical research, highlighting several advancements they have helped make in recent years, such as with curative gene therapy, among others. The ASH has also commended the fact that the allocated funding is an increase from the previous fiscal year.

# data[].attributes.attachment_link.title
ASH Commends Congress for Reaching Spending Deal

# data[].attributes.attachment_link.description
Drawing on several decades of experience, Dr. Jagjit Tandon is a medical professional who serves as the director and CEO of Bradford Oncology, a practice he established in 2007. Throughout his career, Dr. Jagjit Tandon has been involved with several organizations, including the American Society of Hematology (ASH), which looks to advance blood disease research.

# data[].attributes.body
Dr. Jagjit Tandon is the CEO and founder of Bradford Oncology, an oncology/hematology practice affiliated to several hospitals. With over 25 years of experience practicing in the United States, Dr. Jagjit Tandon is actively involved in oncology research around treatments for cervical cancer.

# data[].attributes.attachment_link.readable_text
Pink ribbon Photo by Miguel Á. Padriñán from Pexels

Dr. Jagjit Tandon is the CEO and founder of Bradford Oncology, an oncology/hematology practice affiliated to several hospitals. With over 25 years of experience practicing in the United States, Dr. Jagjit Tandon is actively involved in oncology research around treatments for cervical cancer.

Treatments for cervical cancer vary depending on the stage of cancer, the side effects patients may experience, and their overall health. Generally, the treatments include chemotherapy, radiotherapy, and surgery.

When a tumor is in its early stages, radiotherapy and chemotherapy are often advised. Radiotherapy can be external or internal. External radiotherapy is where a patient is exposed to a high-power x-ray beam delivered externally, bathing her in radiation that's intended to kill cancer cells. Internal radiotherapy is where radioactive material is implanted into the body at the site of cancer, localizing radiation treatment and destroying the cancer cells.

Chemotherapy involves the use of medication to destroy cancer by preventing it from growing and dividing. Medication for cervical cancer, though, is delivered intravenously (injected into the veins).

For cancers that have advanced, surgery may be the best option. It may take the form of conization where a process similar to a cone biopsy is used to extract abnormal tissue, LEEP where doctors use a thin wire hook to pass electric current that removes cancer, a hysterectomy where the uterus and cervix are removed, or a more radical surgery where other parts of the patient's sexual organs are removed including the ovaries, fallopian tubes, and upper vagina. Because these treatments have side effects, women are encouraged to talk to their doctors openly about them, especially with regard to those that affect sexual health and fertility.

# data[].attributes.attachment_link.description
Dr. Jagjit Tandon is the CEO and founder of Bradford Oncology, an oncology/hematology practice affiliated to several hospitals. With over 25 years of experience practicing in the United States, Dr. Jagjit Tandon is actively involved in oncology research around treatments for cervical cancer.